Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea.
Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea.
复制标题
艰难梭菌试点研究:补充益生菌对艰难梭菌腹泻发病率的影响。
DOI:
--
复制
发表时间:
2004
影响因子:
3.1
通讯作者:
J. Hunter
中科院分区:
文献类型:
--
作者:
S. Plummer;M. Weaver;Janine C. Harris;Phillipa Dee;J. Hunter
Colonic infection with Clostridium difficile, leading to pseudomembranous colitis, is a common complication of antibiotic therapy, especially in elderly patients. It has been suggested that non-pathogenic probiotic bacteria might prevent the development and recurrence of C. difficile infection. This double-blind, placebo-controlled study examines the role of probiotic administration in the prevention of C. difficile-associated diarrhoea (CDAD) in elderly patients receiving antibiotic therapy. Consecutive patients (150) receiving antibiotic therapy were randomised to receive either a probiotic containing both Lactobacillus and Bifidobacterium or placebo for 20 days. Upon admission to hospital, bowel habit was recorded and a faecal sample taken. Trial probiotic or placebo was taken within 72 h of prescription of antibiotics, and a second stool sample was taken in the event of development of diarrhoea during hospitalisation or after discharge. Of the randomised patients, 138 completed the study, 69 with probiotics in conjunction with antibiotics and 69 with antibiotics alone. On the basis of development of diarrhoea, the incidence of samples positive for C. difficile-associated toxins was 2.9% in the probiotic group compared with 7.25% in the placebo-control group. When samples from all patients were tested (rather than just those developing diarrhoea) 46% of probiotic patients were toxin-positive compared with 78% of the placebo group.
影响因子:
0.8
作者:
Tang,DerekM;Urrunaga,NathalieH;DeGroot,Hannah;vonRosenvinge,ErikC;Xie,Guofeng;Ghazi,LeylaJ
通讯作者:
Ghazi,LeylaJ